Clinical trials: Second Primary Lung Cancer (SPLC)

Lung Neoplasms, Second Primary Lung Cancer (SPLC)

Advancing Precision Lung Cancer Surveillance and Outcomes in Diverse Populations

• Active, not recruiting
• Age: All ages
• Observational study

This observational study evaluates the effectiveness of computed tomography (CT) imaging surveillance after curative-intent treatment for stage I-IIIA non-small cell lung cancer (NSCLC) in a diverse U.S. population.

Conditions

Lung Neoplasms, Second Primary Lung Cancer (SPLC), Non-Small Cell Lung Cancer (NSCLC), Stage I-IIIA, Lung Cancer (Diagnosis)

Trial name

PLuS2 (NCT07581379)

Where

United States

Volunteers

1,826 people

Sponsor

University of Florida